Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The global burden of psoriatic skin disease.

Literature DB >> 25645671

The global burden of psoriatic skin disease.

K L Goff¹, C Karimkhani², L N Boyers³, M A Weinstock^4,5,6, J P Lott^7,8, R J Hay⁹, L E Coffeng¹⁰, S A Norton¹¹, L Naldi¹², C Dunnick^13,14, A W Armstrong^13,14, R P Dellavalle^13,14,15.

Abstract

Entities: Disease

Mesh：

Year: 2015 PMID： 25645671 DOI： 10.1111/bjd.13715

Source DB: PubMed Journal: Br J Dermatol ISSN： 0007-0963 Impact factor: 9.302

Keyword Cloud
Cited

× No keyword cloud information.

19 in total

1. [Not Available].

Authors: Firas George Hougeir; Fran E Cook-Bolden; David Rodriguez; Joshua M Berlin
Journal: J Clin Aesthet Dermatol Date: 2015-05

2. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.

Authors: C Liu; H Liu; C Lu; J Deng; Y Yan; H Chen; Y Wang; C-L Liang; J Wei; L Han; Z Dai
Journal: Clin Exp Immunol Date: 2019-08-26 Impact factor: 4.330

3. Interleukin-21 is associated with the severity of psoriasis vulgaris through promoting CD4+ T cells to differentiate into Th17 cells.

Authors: Ying Wang; Li-Li Wang; Hao-Yu Yang; Fei-Fei Wang; Xue-Xiu Zhang; Yan-Ping Bai
Journal: Am J Transl Res Date: 2016-07-15 Impact factor: 4.060

4. Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial.

Authors: Nehal N Mehta; Daniel B Shin; Aditya A Joshi; Amit K Dey; April W Armstrong; Kristina Callis Duffin; Zelma Chiesa Fuxench; Charlotte L Harrington; Rebecca A Hubbard; Robert E Kalb; Alan Menter; Daniel J Rader; Muredach P Reilly; Eric L Simpson; Junko Takeshita; Drew A Torigian; Thomas J Werner; Andrea B Troxel; Stephen K Tyring; Suzette Baez Vanderbeek; Abby S Van Voorhees; Martin P Playford; Mark A Ahlman; Abass Alavi; Joel M Gelfand
Journal: Circ Cardiovasc Imaging Date: 2018-06 Impact factor: 7.792

5. Evolution of Cooperation Patterns in Psoriasis Research: Co-Authorship Network Analysis of Papers in Medline (1942-2013).

Authors: Gregorio González-Alcaide; Jinseo Park; Charles Huamaní; Isabel Belinchón; José M Ramos
Journal: PLoS One Date: 2015-12-11 Impact factor: 3.240

6. Abstract analysis method facilitates filtering low-methodological quality and high-bias risk systematic reviews on psoriasis interventions.

Authors: Francisco Gómez-García; Juan Ruano; Macarena Aguilar-Luque; Patricia Alcalde-Mellado; Jesús Gay-Mimbrera; José Luis Hernández-Romero; Juan Luis Sanz-Cabanillas; Beatriz Maestre-López; Marcelino González-Padilla; Pedro J Carmona-Fernández; Antonio Vélez García-Nieto; Beatriz Isla-Tejera
Journal: BMC Med Res Methodol Date: 2017-12-29 Impact factor: 4.615

The global burden of psoriatic skin disease.

1. [Not Available].

2. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.

3. Interleukin-21 is associated with the severity of psoriasis vulgaris through promoting CD4+ T cells to differentiate into Th17 cells.

4. Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial.

5. Evolution of Cooperation Patterns in Psoriasis Research: Co-Authorship Network Analysis of Papers in Medline (1942-2013).

6. Abstract analysis method facilitates filtering low-methodological quality and high-bias risk systematic reviews on psoriasis interventions.

7. Model-Based Meta-Analysis in Psoriasis: A Quantitative Comparison of Biologics and Small Targeted Molecules.

Review 8. Association Between Psoriasis and Subclinical Atherosclerosis: A Meta-Analysis.

9. Lipoxin A4 and its analog suppress inflammation by modulating HMGB1 translocation and expression in psoriasis.

Review 10. Transcription Factor Retinoid-Related Orphan Receptor γt: A Promising Target for the Treatment of Psoriasis.